Delivery Order SPE2DB22D2206-SPE2DB25FHL61
Award Date
6/16/25
Potential Completion Date
6/17/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a prescription medication, with an ultimate completion date of June 10, 2025 and a ceiling value of $1,032.01. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4568448460 QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,976.80. The contract type is a delivery order under a firm fixed price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific pharmaceutical product, QSYMIA 3.75 MG-23 MG CAPSULE 30S, with a ceiling value of $1,110.96 and a completion date of June 4, 2025. The contract type is Firm Fixed Price. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $1,630.25, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of QSYMIA 3.75 MG-23 MG capsules in 30-count packages. The contract has a firm fixed price and an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568520731 - QSYMIA 3.75 MG-23 MG CAPSULE 30S, a prescription medication. The total ceiling value of the contract is $1,587.98, with a firm fixed price pricing type. The contract has an ultimate completion date of June 12, 2025. This appears to be a non-set-aside...
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB25FH9ZH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.44 firm-fixed-price delivery order is for the supply of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. This award is not designated as a set-aside contract....
This federal contract award is for the delivery of QSYMIA 7.5 MG-46 MG capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $6,251.20 and a completion date of September 10, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order, with a firm fixed-price pricing type. This award is not associated with a set-aside...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of QSYMIA 3.75 MG-23 MG capsules, with a ceiling value of $4,145.22 and a completion date of September 11, 2024. This contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen is a prominent supplier of pharmaceutical products and medical supplies to various federal...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.32, is for the supply of Qsymia 15 mg-92 mg capsules. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...